Navigation Links
International Panel of Experts Gather for Roundtable Consensus Regarding Multiple Myeloma Related Disease

LOS ANGELES, Feb. 23 /PRNewswire-USNewswire/ -- On Wednesday, February 25, 2009, the Institute for Myeloma and Bone Cancer Research (IMBCR) will host a roundtable discussion bringing leading scientists in the field of cancer research together to discuss monoclonal gammopathy of undetermined significance (MGUS). The event is being cochaired by James R. Berenson, MD, who is Medical and Scientific Director at the IMBCR and Robert A. Kyle, MD, who is Professor of Medicine at the Mayo Clinic.

The goal of this roundtable discussion is to develop a consensus statement to be published in a major medical journal related to all aspects regarding the evaluation, follow-up and treatment of patients at risk for MGUS and its associated bone loss and fracture.

Topics for discussion include: addressing important issues such as which patients should be screened and how often; specific types of work-ups for patients; diagnostic testing for evaluation of bone disease; treatment measures for patients with significant bone loss and fractures; and other potential studies to be conducted for this disease population.

The event will take place February 25th at the Marriott Wardman Park Hotel just prior to the 12th Annual International Myeloma Workshop in Washington, D.C.

MGUS is a common condition in which a monoclonal paraprotein is detected in the blood and/or urine but these patients do not have a malignant disorder associated with the presence of this protein. More than 3% of individuals over 50 years of age and 5% of individuals over 70 have this condition. Studies show these individuals have an increased risk to develop cancers including myeloma and lymphoma with a very high risk of bone loss and fractures. There is no current consensus on the work-up, follow-up and treatment of patients with MGUS.

The Institute for Myeloma and Bone Cancer Research is a non-profit organization headquartered in Los Angeles, California. IMBCR is the only independent cancer research institute working to find improved treatment and ultimately a cure for multiple myeloma and other blood cancers. Drs. Berenson, Kyle and the IMBCR research team have been published in most major oncology journals such as the New England Journal of Medicine, Mayo Clinic Proceedings, BLOOD, Journal of Clinical Oncology, Science, Proceedings of the National Academy of Sciences, Cancer, Clinical Cancer Research, Clinical Lymphoma and Myeloma, Nature, Oncogene and the British Journal of Haematology.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

James R. Berenson, MD

SOURCE Institute for Myeloma and Bone Cancer Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Health-E-minds ... collaborated with Women’s Web – an online resource for Indian women looking ... and emotional well-being relationship, life balance, stress, professional development, and lifestyle. Health-E-minds ...
(Date:11/25/2015)... ... 25, 2015 , ... The holiday season is jam-packed with ... palates of attendees is of the utmost importance. Whether you are cooking at ... these recipes a try this holiday season. , Turkey Croquettes , ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless ... treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, ... without the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro ...
(Date:11/25/2015)... ... 25, 2015 , ... According to an article published November 10th ... widely heralded as a breakthrough for performing hernia repairs. The article explains that the ... is that it can greatly reduce the pain that a patient might otherwise experience ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... athletic programs, launches new Wimbledon Athletics Facebook page to educate the ... for unsuspected cardiac abnormalities. About 2,000 people under the age of 25 die ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... "Advanced Wound Care Market by Type (Dressings, Therapy Devices, ... (In-Patient Facility, Out-Patient Facility), and Geography - Global Forecast ... --> --> The purpose ... and forecast of the global advanced wound care market. ...
(Date:11/26/2015)... India , November 26, 2015 ... --> adds ... Report" and "Investigation Report on China ... and 2021 forecasts data and information ... . ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
Breaking Medicine Technology: